ArticleCureus2023

A Comparative Study on the Efficacy and Safety of Dose Escalation of Luseogliflozin in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control.

Tadashi Arao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.